{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T13:01:45Z","timestamp":1701867705434},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.lpm.2016.04.011","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T10:10:52Z","timestamp":1464084652000},"page":"903-910","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Stratification du risque de la mort subite dans la cardiomyopathie hypertrophique en 2016"],"prefix":"10.1016","volume":"45","author":[{"given":"Olivier","family":"Dubourg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Charron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Sirol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Siam-Tsieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Mansencal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2016.04.011_bib0155","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014\u00a0ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force m","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2016.04.011_bib0160","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","article-title":"A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines","volume":"42","author":"Maron","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2016.04.011_bib0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.15420\/ecr.2015.10.01.31","article-title":"Risk stratification in hypertrophic cardiomyopathy","volume":"10","author":"Steriotis","year":"2015","journal-title":"Eur Cardiol Rev"},{"key":"10.1016\/j.lpm.2016.04.011_bib0170","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1161\/CIRCULATIONAHA.107.189375","volume":"118","author":"Goldberger","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2016.04.011_bib0175","series-title":"Cardiomyopathie hypertrophique\u00a0: protocole national de diagnostic et de soins pour les maladies rares","author":"Dubourg","year":"2011"},{"key":"10.1016\/j.lpm.2016.04.011_bib0180","doi-asserted-by":"crossref","first-page":"e783","DOI":"10.1161\/CIR.0b013e318223e2bd","article-title":"2011\u00a0ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2016.04.011_bib0185","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0735-1097(00)01003-2","article-title":"Sudden death in hypertrophic cardiomyopathy: identification of high risk patients","volume":"36","author":"Elliott","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2016.04.011_bib0190","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/hrt.2005.071308","article-title":"Clinical genetics in cardiology","volume":"92","author":"Charron","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.lpm.2016.04.011_bib0195","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0735-1097(02)03004-8","article-title":"Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration","volume":"41","author":"Kofflard","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2016.04.011_bib0200","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200002103420601","article-title":"Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy","volume":"342","author":"Maron","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2016.04.011_bib0205","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0735-1097(99)00056-X","article-title":"Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy","volume":"33","author":"Elliott","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2016.04.011_bib0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/heart.87.2.169","article-title":"Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death","volume":"87","author":"McKenna","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.lpm.2016.04.011_bib0215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0735-1097(86)80092-4","article-title":"Hypertrophic cardiomyopathy with extreme increase in left ventricular wall thickness: functional and morphologic features and clinical significance","volume":"8","author":"Louie","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2016.04.011_bib0220","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJM200006153422403","article-title":"Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy","volume":"342","author":"Spirito","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2016.04.011_bib0225","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1053\/euhj.2001.2824","article-title":"Task Force on sudden cardiac death of the European Society of Cardiology","volume":"22","author":"Priori","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2016.04.011_bib0230","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0735-1097(89)90222-2","article-title":"Relation between extent of left ventricular hypertrophy and age in hypertrophic cardiomyopathy","volume":"13","author":"Spirito","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2016.04.011_bib0235","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.112.136085","article-title":"Risk stratification and outcome of patients with hypertrophic cardiomyopathy\u226560years of age","volume":"127","author":"Maron","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2016.04.011_bib0240","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2016.04.011_bib0245","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1046\/j.1540-8167.2002.00954.x","article-title":"Atrial fibrillation precipitating sustained ventricular tachycardia in hypertrophic cardiomyopathy","volume":"13","author":"Boriani","year":"2002","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.lpm.2016.04.011_bib0250","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/europace\/eul097","volume":"8","author":"Fuster","year":"2006","journal-title":"Europace"},{"key":"10.1016\/j.lpm.2016.04.011_bib0255","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1161\/01.CIR.0000097110.55312.BF","article-title":"Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease","volume":"108","author":"Sorajja","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2016.04.011_bib0260","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa021332","article-title":"Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy","volume":"348","author":"Maron","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2016.04.011_bib0265","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.jacc.2011.02.033","article-title":"Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy","volume":"57","author":"Minami","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2016.04.011_bib0270","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1253\/circj.CJ-12-1561","article-title":"Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction","volume":"77","author":"Efthimiadis","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.lpm.2016.04.011_bib0275","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcmg.2011.11.021","article-title":"Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy","volume":"5","author":"Green","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.lpm.2016.04.011_bib0280","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2016.04.011_bib0285","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.acvd.2014.12.002","article-title":"Recommendations for the diagnosis and management of hypertrophic cardiomyopathy in 2014","volume":"108","author":"Dubourg","year":"2015","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.lpm.2016.04.011_bib0290","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jama.298.4.405","article-title":"Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"298","author":"Maron","year":"2007","journal-title":"Jama"},{"key":"10.1016\/j.lpm.2016.04.011_bib0295","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/CIRCEP.114.002553","article-title":"Validation of the 2014\u00a0European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"8","author":"Vriesendorp","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.lpm.2016.04.011_bib0150","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.amjcard.2015.05.047","article-title":"Independent assessment of the European Society of Cardiology sudden death risk model for hypertrophic cardiomyopathy","volume":"116","author":"Maron","year":"2015","journal-title":"Am J Cardiol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498216300689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498216300689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T16:50:09Z","timestamp":1536684609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498216300689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0755498216300689"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2016.04.011","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stratification du risque de la mort subite dans la cardiomyopathie hypertrophique en 2016","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2016.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}